UK phage biotechnology company names new chief executive
Fixed Phage has appointed Dr Neil Clelland as its new CEO.
The biotech has also announced its new chief operations officer and executive chairman. These appointments, it said, strengthen the top management team, leading the company as it drives forward its new phase of growth and development.
Dr Clelland, formerly the business’s commercial director, takes over from outgoing CEO, David Browning, who has stepped down after almost four years in the role.
He brings extensive experience in business development, deal structure and company creation to the role, said Fixed Phage. Dr Clelland also has a strong record in identifying and developing innovative commercial opportunities within complex scientific output and environments, added the firm.
Commenting on his appointment, the new CEO said: “I am extremely excited to have taken up this position and look forward to building on David’s legacy to take Fixed Phage to even greater heights. The phage industry is thriving and there is so much potential in this company and the talents we have here to raise the bar in providing innovative solutions for human and animal health.”
The company, based in Glasgow, has also appointed Chris Bindon – formerly director of technical operations – as its new COO, and Simon Hunt, previously chairman, is now the biotech’s executive chairman.
